Medi-Caps informs about updates

24 May 2025 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in furtherance to intimation dated 24th February,2025, Medi-Caps has informed that the United States Food & Drug Administration (USFDA) conducted an inspection at the manufacturing facility of Wholly Owned Subsidiary Company, Medgel at Pithampur, Madhya Pradesh, from 17th to 21st February, 2025 and it has informed that the company has received a communication from US FDA indicating that the inspection classification of this facility as ‘Voluntary Action Indicated’ (VAI). FDA has concluded that this inspection is ‘closed’ under 21 CFR 20.64 (d) (3). The above information will also be available on the website of the Company at www.medicaps.com.

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

30.44 -2.56 (-7.76%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3635.80
Tata Chemicals 755.60
SRF 3025.85
Pidilite Inds. 1476.20
Deepak Nitrite 1547.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×